arXiv subjects

Tuo Wang

Publications and source records attributed to Tuo Wang.

At least 19 recordsLinked to original sources

arXiv2026

The Emerging AI Paper-Review Arms Race: Adversarial Co-Evolution in Scholarly Publishing

Generative and agentic AI are reshaping both the production and evaluation of scientific research. These developments are often studied separately, as questions of how AI can produce research and how AI can review it. We argue that this separation misses an increasingly important feature of scholarly publishing: changes on one side alter the incentives, constraints, and behavior of the other. We synthesize 230 scholarly publications and institutional records using a taxonomy of six connected dynamics: production scaling, evaluation automation, evaluation manipulation, defense mechanisms and policy responses, evasion and side effects, and long-horizon ecosystem feedback. The literature shows an emerging progression in which cheaper and faster research production increases pressure on evaluation, AI-mediated evaluation becomes more scalable and repeatable, participants can exploit evaluator regularities, and institutions respond with technical safeguards and policy controls. These responses can in turn induce evasion, redistribute errors and workload, and shape the scholarly records reused by future research and evaluation systems. Evidence is strongest for production and evaluation at scale, reproducible manipulation, and institutional response, while post-policy adaptation and artifact-level long-horizon feedback remain less directly observed. This systems view shifts attention from isolated AI capabilities toward how scholarly actors and AI systems adapt to one another over time.

cs.AI↗

arXiv2026

Shape-Preserving Covariate Adjustment via Empirical Likelihood in Randomized Experiment

Covariate adjustment improves estimation efficiency in randomized experiments, but standard calibration and augmentation methods, when applied to distribution or survival functions, do not preserve monotonicity---a fundamental property of the estimand. We propose using empirical likelihood with covariate-balancing constraints to construct a covariate-adjusted empirical measure for each treatment arm. Estimators of a broad class of distributional functionals, including cumulative distribution functions, survival functions, quantiles, and restricted mean survival times, are then derived as plug-in functionals of this measure, automatically inheriting proper shape constraints. We establish asymptotic normality with an explicit, guaranteed efficiency gain over unadjusted estimators. The asymptotic distributions are invariant to the randomization scheme, providing a unified inference procedure under simple randomization and all commonly used covariate-adaptive designs satisfying a mild balancing condition. This unified construction, adjusting the empirical measure once and deriving all estimators from it, offers a principled reconciliation of covariate adjustment with shape preservation. Simulations and an application to the SURPASS-4 trial confirm the theoretical gains.

stat.ME↗

arXiv2026

Bridging Balancing Weights and Augmentation in Covariate-adjusted Analyses with Time-to-Event Endpoints: Theory and Practical Recommendations

Covariate adjustment improves the efficiency of treatment-effect analyses in randomized clinical trials, provided the adjustment targets the correct quantity. For time-to-event endpoints, two marginal targets are of primary interest: the log-rank test for the presence of a treatment effect and the marginal hazard ratio for its magnitude. Existing covariate adjustment approaches reach these targets by different ways. Augmentation adjusts the log-rank score by regressing derived outcomes on the baseline covariates within each arm. Weighting instead reweights the two arms to balance the covariates before the survival comparison is formed: inverse probability weighting does so through a fitted propensity model, while calibration weighting solves directly for weights that match covariate means. In this manuscript, we first develop balancing weighting for time-to-event endpoints, covering both calibration weights (stable balancing weights and entropy balancing) and propensity score weights, and prove that any balancing-regular weighting is first-order equivalent to the augmented log-rank score and to the root of the marginal Cox score. All three routes therefore deliver the same estimator to first order, and calibration reaches it without fitting any model. The weighted procedures thereby inherit the validity and guaranteed efficiency gain of the augmentation approach. In addition, we show that the efficiency gain grows with the prognostic strength of the adjustment covariates, while the practical caveat lies in variance estimation, for which we give recommendations to guard against finite-sample Type I error inflation. We further confirm our results through simulation studies and an analysis of the REWIND cardiovascular trial.

stat.ME↗

arXiv2026

GloResNet: A lightweight 3D CNN with global topological features for preterm brain injury prediction

This study introduces an automated deep learning framework for predicting brain injury (BI) in preterm infants from T2-weighted MRI (dHCP dataset). We propose GloResNet, a lightweight 3D CNN based on ResNet-10, pretrained on MedicalNet to address data scarcity. A global manifold mapping strategy first resamples each 3D volume to 128x128x128 and then applies subject-wise z-score intensity normalization, thereby preserving global topology while standardizing appearance. Training integrates mixup, class weighting, and test-time augmentation for robustness. In 5-fold cross-validation, GloResNet achieved 75.18% average accuracy (peak 81.82%), with specificity 0.81 and sensitivity 0.76. Results demonstrate that a topology-aware lightweight CNN has the capability to effectively predict neonatal BI, offering a non-invasive screening tool. The source code of this paper can be obtained from the GitHub repository: https://github.com/ICL-SUST/GloResNet-Preterm-Brain

cs.CV↗

arXiv2026

A positive solution to the $L^p$ projection centroid conjecture

In a classical paper [20] in 2000, Lutwak-Yang-Zhang established the $L^p$ analog of the Petty projection inequality and the $L^p$ analog of the Busemann-Petty centroid inequality. In Section 7 of [20], Lutwak-Yang-Zhang proposed the important $L^p$ projection centroid conjecture. We give a positive solution to the $L^p$ projection centroid conjecture in this work.

math.MG↗

arXiv2026

Adaptive receptive field-based spatial-frequency feature reconstruction network for fine-grained few-shot image classification

Feature reconstruction techniques are widely applied for few-shot fine-grained image classification (FSFGIC). Our research indicates that one of the main challenges facing existing feature-based FSFGIC methods is how to choose the size of the receptive field to extract feature descriptors (including spatial and frequency feature descriptors) from different category input images, thereby better performing the FSFGIC tasks. To address this, an adaptive receptive field-based spatial-frequency feature reconstruction network (ARF-SFR-Net) is proposed. The designed ARF-SFR-Net has the capability to adaptively determine receptive field sizes for obtaining spatial and frequency features, and effectively fuse them for reconstruction and FSFGIC tasks. The designed ARF-SFR-Net can be easily embedded into a given episodic training mechanism for end-to-end training from scratch. Extensive experiments on multiple FSFGIC benchmarks demonstrate the effectiveness and superiority of the proposed ARF-SFR-Net over state-of-the-art approaches. The code is available at: https://github.com/ICL-SUST/ARF-SFR-Net.

cs.CV↗

arXiv2026

Competing Risk Analysis in Cardiovascular Outcome Trials: A Simulation Comparison of Cox and Fine-Gray Models

Cardiovascular outcome trials commonly face competing risks when non-CV death prevents observation of major adverse cardiovascular events (MACE). While Cox proportional hazards models treat competing events as independent censoring, Fine-Gray subdistribution hazard models explicitly handle competing risks, targeting different estimands. This simulation study using bivariate copula models systematically varies competing event rates (0.5%-5% annually), treatment effects on competing events (50% reduction to 50% increase), and correlation structures to compare these approaches. At competing event rates typical of CV outcome trials (~1% annually), Cox and Fine-Gray produce nearly identical hazard ratio estimates regardless of correlation strength or treatment effect direction. Substantial divergence occurs only with high competing rates and directionally discordant treatment effects, though neither estimator provides unbiased estimates of true marginal hazard ratios under these conditions. In typical CV trial settings with low competing event rates, Cox models remain appropriate for primary analysis due to superior interpretability. Pre-specified Cox models should not be abandoned for competing risk methods. Importantly, Fine-Gray models do not constitute proper sensitivity analyses to Cox models per ICH E9(R1), as they target different estimands rather than testing assumptions. As supplementary analysis, cumulative incidence using Aalen-Johansen estimator can provide transparency about competing risk impact. Under high competing-risk scenarios, alternative approaches such as inverse probability of censoring weighting, multiple imputation, or inclusion of all-cause mortality in primary endpoints warrant consideration.

stat.ME↗

arXiv2026

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test

We apply covariate adjustment to the Wincoxon two sample statistic and Wincoxon-Mann-Whitney test in comparing two treatments. The covariate adjustment through calibration not only improves efficiency in estimation/inference but also widens the application scope of the Wilcoxon two sample statistic and Wincoxon-Mann-Whitney test to situations where covariate-adaptive randomization is used. We motivate how to adjust covariates to reduce variance, establish the asymptotic distribution of adjusted Wincoxon two sample statistic, and provide explicitly the guaranteed efficiency gain. The asymptotic distribution of adjusted Wincoxon two sample statistic is invariant to all commonly used covariate-adaptive randomization schemes so that a unified formula can be used in inference regardless of which covariate-adaptive randomization is applied.

stat.ME↗

arXiv2026

Meningioma Analysis and Diagnosis using Limited Labeled Samples

The biological behavior and treatment response of meningiomas depend on their grade, making an accurate diagnosis essential for treatment planning and prognosis assessment. We observed that the weighted fusion of spatial-frequency domain features significantly influences meningioma classification performance. Notably, the contribution of specific frequency bands obtained by discrete wavelet transform varies considerably across different images. A feature fusion architecture with adaptive weights of different frequency band information and spatial domain information is proposed for few-shot meningioma learning. To verify the effectiveness of the proposed method, a new MRI dataset of meningiomas is introduced. The experimental results demonstrate the superiority of the proposed method compared with existing state-of-the-art methods in three datasets. The code will be available at: https://github.com/ICL-SUST/AMSF-Net

cs.CV↗

arXiv2026

Capturing Cumulative Disease Burden in Chronic Kidney Disease Outcome Trials: Area Under the Curve and Restricted Mean Time in Favor of Treatment Beyond Conventional Time-to-First Analysis

Chronic kidney disease (CKD) affects millions worldwide and progresses irreversibly through stages culminating in end-stage renal disease (ESRD) and death. Outcome trials in CKD traditionally employ time-to-first-event analyses using the Cox models. However, this approach has fundamental limitations for progressive diseases: it assigns equal weight to each composite endpoint component despite clear clinical hierarchy: an eGFR decline threshold receives the same weight as ESRD or death in the analysis, and it captures only the first occurrence while ignoring subsequent progression. Given CKD's gradual evolution over years, comprehensive treatment evaluation requires quantifying cumulative disease burden: integrating both event severity and time spent in each disease state. We propose two complementary approaches to better characterize treatment benefits by incorporating event severity and state occupancy: area under the curve (AUC) and restricted mean time in favor of treatment (RMT-IF). The AUC method assigns ordinal severity scores to disease states and calculates the area under the mean cumulative score curve, quantifying total event-free time lost. Treatment effects are expressed as AUC ratios or differences. The RMT-IF extends restricted mean survival time to multistate processes, measuring average time patients in the treatment arm spend in more favorable states versus the comparator. These methods better capture CKD's progressive nature where treatment benefits extend beyond first-event delay to overall disease trajectory modification. By discriminating between events of differing clinical importance and quantifying the complete disease course, these estimands offer alternative assessment frameworks for kidney-protective therapies, potentially improving efficiency and interpretability of future CKD outcome trials.

stat.ME↗

arXiv2026

Deep learning-based neurodevelopmental assessment in preterm infants

Preterm infants (born between 28 and 37 weeks of gestation) face elevated risks of neurodevelopmental delays, making early identification crucial for timely intervention. While deep learning-based volumetric segmentation of brain MRI scans offers a promising avenue for assessing neonatal neurodevelopment, achieving accurate segmentation of white matter (WM) and gray matter (GM) in preterm infants remains challenging due to their comparable signal intensities (isointense appearance) on MRI during early brain development. To address this, we propose a novel segmentation neural network, named Hierarchical Dense Attention Network. Our architecture incorporates a 3D spatial-channel attention mechanism combined with an attention-guided dense upsampling strategy to enhance feature discrimination in low-contrast volumetric data. Quantitative experiments demonstrate that our method achieves superior segmentation performance compared to state-of-the-art baselines, effectively tackling the challenge of isointense tissue differentiation. Furthermore, application of our algorithm confirms that WM and GM volumes in preterm infants are significantly lower than those in term infants, providing additional imaging evidence of the neurodevelopmental delays associated with preterm birth. The code is available at: https://github.com/ICL-SUST/HDAN.

cs.CV↗

arXiv2025

DiagnoLLM: A Hybrid Bayesian Neural Language Framework for Interpretable Disease Diagnosis

Building trustworthy clinical AI systems requires not only accurate predictions but also transparent, biologically grounded explanations. We present \texttt{DiagnoLLM}, a hybrid framework that integrates Bayesian deconvolution, eQTL-guided deep learning, and LLM-based narrative generation for interpretable disease diagnosis. DiagnoLLM begins with GP-unmix, a Gaussian Process-based hierarchical model that infers cell-type-specific gene expression profiles from bulk and single-cell RNA-seq data while modeling biological uncertainty. These features, combined with regulatory priors from eQTL analysis, power a neural classifier that achieves high predictive performance in Alzheimer's Disease (AD) detection (88.0\% accuracy). To support human understanding and trust, we introduce an LLM-based reasoning module that translates model outputs into audience-specific diagnostic reports, grounded in clinical features, attribution signals, and domain knowledge. Human evaluations confirm that these reports are accurate, actionable, and appropriately tailored for both physicians and patients. Our findings show that LLMs, when deployed as post-hoc reasoners rather than end-to-end predictors, can serve as effective communicators within hybrid diagnostic pipelines.

cs.AI↗

arXiv2025

GENUINE: Graph Enhanced Multi-level Uncertainty Estimation for Large Language Models

Uncertainty estimation is essential for enhancing the reliability of Large Language Models (LLMs), particularly in high-stakes applications. Existing methods often overlook semantic dependencies, relying on token-level probability measures that fail to capture structural relationships within the generated text. We propose GENUINE: Graph ENhanced mUlti-level uncertaINty Estimation for Large Language Models, a structure-aware framework that leverages dependency parse trees and hierarchical graph pooling to refine uncertainty quantification. By incorporating supervised learning, GENUINE effectively models semantic and structural relationships, improving confidence assessments. Extensive experiments across NLP tasks show that GENUINE achieves up to 29% higher AUROC than semantic entropy-based approaches and reduces calibration errors by over 15%, demonstrating the effectiveness of graph-based uncertainty modeling. The code is available at https://github.com/ODYSSEYWT/GUQ.

cs.CL↗

arXiv2025

Non-exchangeable Conformal Prediction for Temporal Graph Neural Networks

Conformal prediction for graph neural networks (GNNs) offers a promising framework for quantifying uncertainty, enhancing GNN reliability in high-stakes applications. However, existing methods predominantly focus on static graphs, neglecting the evolving nature of real-world graphs. Temporal dependencies in graph structure, node attributes, and ground truth labels violate the fundamental exchangeability assumption of standard conformal prediction methods, limiting their applicability. To address these challenges, in this paper, we introduce NCPNET, a novel end-to-end conformal prediction framework tailored for temporal graphs. Our approach extends conformal prediction to dynamic settings, mitigating statistical coverage violations induced by temporal dependencies. To achieve this, we propose a diffusion-based non-conformity score that captures both topological and temporal uncertainties within evolving networks. Additionally, we develop an efficiency-aware optimization algorithm that improves the conformal prediction process, enhancing computational efficiency and reducing coverage violations. Extensive experiments on diverse real-world temporal graphs, including WIKI, REDDIT, DBLP, and IBM Anti-Money Laundering dataset, demonstrate NCPNET's capability to ensure guaranteed coverage in temporal graphs, achieving up to a 31% reduction in prediction set size on the WIKI dataset, significantly improving efficiency compared to state-of-the-art methods. Our data and code are available at https://github.com/ODYSSEYWT/NCPNET.

cs.LG↗

arXiv2025

DISPROTBENCH: Uncovering the Functional Limits of Protein Structure Prediction Models in Intrinsically Disordered Regions

Intrinsically disordered regions (IDRs) play central roles in cellular function, yet remain poorly evaluated by existing protein structure prediction benchmarks. Current evaluations largely focus on well-folded domains, overlooking three fundamental challenges in realistic biological settings: the structural complexity of proteins, the resulting low availability of reliable ground truth, and prediction uncertainty that can propagate into high-risk downstream failures, such as in drug discovery, protein-protein interaction modeling, and functional annotation. We present DisProtBench, an IDR-centric benchmark that explicitly incorporates prediction uncertainty into the evaluation of protein structure prediction models (PSPMs). To address structural complexity and ground-truth scarcity, we curate and unify a large-scale, multi-modal dataset spanning disease-relevant IDRs, GPCR-ligand interactions, and multimeric protein complexes. To assess predictive uncertainty, we introduce Functional Uncertainty Sensitivity (FUS), a novel prediction uncertainty-stratified metric that quantifies downstream task performance under prediction uncertainty. Using this benchmark, we conduct a systematic evaluation of state-of-the-art PSPMs and reveal clear, task-dependent failure modes. Protein-protein interaction prediction degrades sharply in IDRs, while structure-based drug discovery remains comparatively robust. These effects are largely invisible to standard global accuracy metrics, which overestimate functional reliability under prediction uncertainty. We have open-sourced our benchmark and the codebase at https://github.com/Susan571/DisProtBench.

q-bio.BM↗

arXiv2025

Estimand framework development for eGFR slope estimation and comparative analyses across various estimation methods

Chronic kidney disease (CKD) is a global health challenge characterized by progressive kidney function decline, often culminating in end-stage kidney disease (ESKD) and increased mortality. To address the limitations such as the extended trial follow-up necessitated by the low incidence of kidney composite endpoint, the eGFR slope -- a surrogate endpoint reflecting the trajectory of kidney function decline -- has gained prominence for its predictive power and regulatory support. Despite its advantages, the lack of a standardized framework for eGFR slope estimand and estimation complicates consistent interpretation and cross-trial comparisons. Existing methods, including simple linear regression and mixed-effects models, vary in their underlying assumptions, creating a need for a formalized approach to align estimation methods with trial objectives. This manuscript proposes an estimand framework tailored to eGFR slope-based analyses in CKD RCTs, ensuring clarity in defining "what to estimate" and enhancing the comparability of results. Through simulation studies and real-world data applications, we evaluate the performance of various commonly applied estimation techniques under distinct scenarios. By recommending a clear characterization for eGFR slope estimand and providing considerations for estimation approaches, this work aims to improve the reliability and interpretability of CKD trial results, advancing therapeutic development and clinical decision-making.

stat.ME↗

arXiv2025

Interpretational challenges of the Win Ratio in analyzing Hierarchical Composite Endpoints in Chronic Kidney Disease

Win statistics based methods have gained traction as a method for analyzing Hierarchical Composite Endpoints (HCEs) in randomized clinical trials, particularly in cardiovascular and kidney disease research. HCEs offer several key advantages, including increased statistical power, mitigation of competing risks, and hierarchical ranking of clinical outcomes. While, as summary measures, the win ratio (WR) along with the Net Benefit (NB) and the Win Odds (WO) provide a structured approach to analyzing HCEs, several concerns regarding their interpretability remain. In this paper, we present known issues with the WR using simple examples designed to explore the implications for the clinical interpretability of the treatment effect measure in the chronic kidney disease setting. Specifically, we discuss the challenge of defining an appropriate estimand in the context of HCEs using the WR, the difficulties in formulating a relevant causal question underlying the WR, and the dependency of the WR on the variance of its components, which complicates its role as an effect measure. Additionally, we highlight the non-collapsibility and non-transitivity of the WR, further complicating its interpretation. While the WR remains a valuable tool in clinical trials, its inherent limitations must be acknowledged to ensure its proper use in regulatory and clinical decision-making.

stat.ME↗

arXiv2024

Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment

The area under the curve (AUC) of the mean cumulative function (MCF) has recently been introduced as a novel estimand for evaluating treatment effects in recurrent event settings, offering an alternative to the commonly used Lin-Wei-Yang-Ying (LWYY) model. The AUC of the MCF provides a clinically interpretable summary measure that captures the overall burden of disease progression, regardless of whether the proportionality assumption holds. To improve the precision of the AUC estimation while preserving its unconditional interpretability, we propose a nonparametric covariate adjustment approach. This approach guarantees efficiency gain compared to unadjusted analysis, as demonstrated by theoretical asymptotic distributions, and is universally applicable to various randomization schemes, including both simple and covariate-adaptive designs. Extensive simulations across different scenarios further support its advantage in increasing statistical power. Our findings highlight the importance of covariate adjustment for the analysis of AUC in recurrent event settings, offering practical guidance for its application in randomized clinical trials.

stat.ME↗